List of Tables
Table 1. Global Absorbable Transdermal Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Absorbable Transdermal Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Absorbable Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Absorbable Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Absorbable Transdermal Patch Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Absorbable Transdermal Patch Sales by Region (2020-2025) & (K Units)
Table 8. Global Absorbable Transdermal Patch Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Absorbable Transdermal Patch Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Absorbable Transdermal Patch Sales Share by Manufacturers (2020-2025)
Table 12. Global Absorbable Transdermal Patch Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Absorbable Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Absorbable Transdermal Patch by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Absorbable Transdermal Patch as of 2024)
Table 16. Global Absorbable Transdermal Patch Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Absorbable Transdermal Patch Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Absorbable Transdermal Patch Manufacturing Base and Headquarters
Table 19. Global Absorbable Transdermal Patch Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Absorbable Transdermal Patch Sales by Type (2020-2025) & (K Units)
Table 23. Global Absorbable Transdermal Patch Sales by Type (2026-2031) & (K Units)
Table 24. Global Absorbable Transdermal Patch Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Absorbable Transdermal Patch Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Absorbable Transdermal Patch ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Absorbable Transdermal Patch Sales by Application (2020-2025) & (K Units)
Table 29. Global Absorbable Transdermal Patch Sales by Application (2026-2031) & (K Units)
Table 30. Absorbable Transdermal Patch High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Absorbable Transdermal Patch Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Absorbable Transdermal Patch Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Absorbable Transdermal Patch ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Absorbable Transdermal Patch Growth Accelerators and Market Barriers
Table 37. North America Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Absorbable Transdermal Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Absorbable Transdermal Patch Growth Accelerators and Market Barriers
Table 40. Europe Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Absorbable Transdermal Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Absorbable Transdermal Patch Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Absorbable Transdermal Patch Growth Accelerators and Market Barriers
Table 45. Southeast Asia Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Absorbable Transdermal Patch Investment Opportunities and Key Challenges
Table 47. Central and South America Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Absorbable Transdermal Patch Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Absorbable Transdermal Patch Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Hisamitsu Pharmaceutical Corporation Information
Table 51. Hisamitsu Pharmaceutical Description and Major Businesses
Table 52. Hisamitsu Pharmaceutical Product Models, Descriptions and Specifications
Table 53. Hisamitsu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Hisamitsu Pharmaceutical Sales Value Proportion by Product in 2024
Table 55. Hisamitsu Pharmaceutical Sales Value Proportion by Application in 2024
Table 56. Hisamitsu Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 57. Hisamitsu Pharmaceutical Absorbable Transdermal Patch SWOT Analysis
Table 58. Hisamitsu Pharmaceutical Recent Developments
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Major Businesses
Table 61. Johnson & Johnson Product Models, Descriptions and Specifications
Table 62. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 64. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 65. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 66. Johnson & Johnson Absorbable Transdermal Patch SWOT Analysis
Table 67. Johnson & Johnson Recent Developments
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Major Businesses
Table 70. Novartis Product Models, Descriptions and Specifications
Table 71. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Novartis Sales Value Proportion by Product in 2024
Table 73. Novartis Sales Value Proportion by Application in 2024
Table 74. Novartis Sales Value Proportion by Geographic Area in 2024
Table 75. Novartis Absorbable Transdermal Patch SWOT Analysis
Table 76. Novartis Recent Developments
Table 77. UCB Pharma Corporation Information
Table 78. UCB Pharma Description and Major Businesses
Table 79. UCB Pharma Product Models, Descriptions and Specifications
Table 80. UCB Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. UCB Pharma Sales Value Proportion by Product in 2024
Table 82. UCB Pharma Sales Value Proportion by Application in 2024
Table 83. UCB Pharma Sales Value Proportion by Geographic Area in 2024
Table 84. UCB Pharma Absorbable Transdermal Patch SWOT Analysis
Table 85. UCB Pharma Recent Developments
Table 86. Mylan Corporation Information
Table 87. Mylan Description and Major Businesses
Table 88. Mylan Product Models, Descriptions and Specifications
Table 89. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Mylan Sales Value Proportion by Product in 2024
Table 91. Mylan Sales Value Proportion by Application in 2024
Table 92. Mylan Sales Value Proportion by Geographic Area in 2024
Table 93. Mylan Absorbable Transdermal Patch SWOT Analysis
Table 94. Mylan Recent Developments
Table 95. Teva Pharmaceutical Corporation Information
Table 96. Teva Pharmaceutical Description and Major Businesses
Table 97. Teva Pharmaceutical Product Models, Descriptions and Specifications
Table 98. Teva Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Teva Pharmaceutical Recent Developments
Table 100. Nitto Denko Corporation Information
Table 101. Nitto Denko Description and Major Businesses
Table 102. Nitto Denko Product Models, Descriptions and Specifications
Table 103. Nitto Denko Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Nitto Denko Recent Developments
Table 105. Grunenthal Corporation Information
Table 106. Grunenthal Description and Major Businesses
Table 107. Grunenthal Product Models, Descriptions and Specifications
Table 108. Grunenthal Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Grunenthal Recent Developments
Table 110. IBSA Group Corporation Information
Table 111. IBSA Group Description and Major Businesses
Table 112. IBSA Group Product Models, Descriptions and Specifications
Table 113. IBSA Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. IBSA Group Recent Developments
Table 115. GSK Corporation Information
Table 116. GSK Description and Major Businesses
Table 117. GSK Product Models, Descriptions and Specifications
Table 118. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. GSK Recent Developments
Table 120. Luye Pharma Group Corporation Information
Table 121. Luye Pharma Group Description and Major Businesses
Table 122. Luye Pharma Group Product Models, Descriptions and Specifications
Table 123. Luye Pharma Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Luye Pharma Group Recent Developments
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Product Models, Descriptions and Specifications
Table 128. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Pfizer Recent Developments
Table 130. Chattem Corporation Information
Table 131. Chattem Description and Major Businesses
Table 132. Chattem Product Models, Descriptions and Specifications
Table 133. Chattem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Chattem Recent Developments
Table 135. Dr Reddy’s Laboratories Corporation Information
Table 136. Dr Reddy’s Laboratories Description and Major Businesses
Table 137. Dr Reddy’s Laboratories Product Models, Descriptions and Specifications
Table 138. Dr Reddy’s Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Dr Reddy’s Laboratories Recent Developments
Table 140. Bayer Corporation Information
Table 141. Bayer Description and Major Businesses
Table 142. Bayer Product Models, Descriptions and Specifications
Table 143. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Bayer Recent Developments
Table 145. Mundipharma Corporation Information
Table 146. Mundipharma Description and Major Businesses
Table 147. Mundipharma Product Models, Descriptions and Specifications
Table 148. Mundipharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Mundipharma Recent Developments
Table 150. Endo International Corporation Information
Table 151. Endo International Description and Major Businesses
Table 152. Endo International Product Models, Descriptions and Specifications
Table 153. Endo International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Endo International Recent Developments
Table 155. Beijing Tide Pharmaceutical Corporation Information
Table 156. Beijing Tide Pharmaceutical Description and Major Businesses
Table 157. Beijing Tide Pharmaceutical Product Models, Descriptions and Specifications
Table 158. Beijing Tide Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Beijing Tide Pharmaceutical Recent Developments
Table 160. Key Raw Materials Distribution
Table 161. Raw Materials Key Suppliers
Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 163. Milestones in Production Technology Evolution
Table 164. Distributors List
Table 165. Market Trends and Market Evolution
Table 166. Market Drivers and Opportunities
Table 167. Market Challenges, Risks, and Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Absorbable Transdermal Patch Product Picture
Figure 2. Global Absorbable Transdermal Patch Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Rivastigmine Transdermal Patch Product Picture
Figure 4. Fentanyl Transdermal Patch Product Picture
Figure 5. Lidocaine Patch Product Picture
Figure 6. Diclofenac Patch Product Picture
Figure 7. Nicotine Transdermal Patch Product Picture
Figure 8. Others Product Picture
Figure 9. Global Absorbable Transdermal Patch Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Absorbable Transdermal Patch Report Years Considered
Figure 14. Global Absorbable Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 16. Global Absorbable Transdermal Patch Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Absorbable Transdermal Patch Revenue Market Share by Region (2020-2031)
Figure 18. Global Absorbable Transdermal Patch Sales (2020-2031) & (K Units)
Figure 19. Global Absorbable Transdermal Patch Sales (CAGR) by Region (2020-2031) (K Units)
Figure 20. Global Absorbable Transdermal Patch Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers Absorbable Transdermal Patch Sales Volume Market Share in 2024
Figure 22. Global Absorbable Transdermal Patch Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Rivastigmine Transdermal Patch Revenue Market Share by Manufacturer in 2024
Figure 25. Fentanyl Transdermal Patch Revenue Market Share by Manufacturer in 2024
Figure 26. Lidocaine Patch Revenue Market Share by Manufacturer in 2024
Figure 27. Diclofenac Patch Revenue Market Share by Manufacturer in 2024
Figure 28. Nicotine Transdermal Patch Revenue Market Share by Manufacturer in 2024
Figure 29. Others Revenue Market Share by Manufacturer in 2024
Figure 30. Global Absorbable Transdermal Patch Sales Market Share by Type (2020-2031)
Figure 31. Global Absorbable Transdermal Patch Revenue Market Share by Type (2020-2031)
Figure 32. Global Absorbable Transdermal Patch Sales Market Share by Application (2020-2031)
Figure 33. Global Absorbable Transdermal Patch Revenue Market Share by Application (2020-2031)
Figure 34. North America Absorbable Transdermal Patch Sales YoY (2020-2031) & (K Units)
Figure 35. North America Absorbable Transdermal Patch Revenue YoY (2020-2031) & (US$ Million)
Figure 36. North America Top 5 Manufacturers Absorbable Transdermal Patch Sales Revenue (US$ Million) in 2024
Figure 37. North America Absorbable Transdermal Patch Sales Volume (K Units) by Type (2020- 2031)
Figure 38. North America Absorbable Transdermal Patch Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 39. North America Absorbable Transdermal Patch Sales Volume (K Units) by Application (2020-2031)
Figure 40. North America Absorbable Transdermal Patch Sales Revenue (US$ Million) by Application (2020-2031)
Figure 41. US Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 42. Canada Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 43. Mexico Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 44. Europe Absorbable Transdermal Patch Sales YoY (2020-2031) & (K Units)
Figure 45. Europe Absorbable Transdermal Patch Revenue YoY (2020-2031) & (US$ Million)
Figure 46. Europe Top 5 Manufacturers Absorbable Transdermal Patch Sales Revenue (US$ Million) in 2024
Figure 47. Europe Absorbable Transdermal Patch Sales Volume (K Units) by Type (2020-2031)
Figure 48. Europe Absorbable Transdermal Patch Sales Revenue (US$ Million) by Type (2020-2031)
Figure 49. Europe Absorbable Transdermal Patch Sales Volume (K Units) by Application (2020-2031)
Figure 50. Europe Absorbable Transdermal Patch Sales Revenue (US$ Million) by Application (2020-2031)
Figure 51. Germany Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 52. France Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 53. U.K. Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 54. Italy Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 55. Russia Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Absorbable Transdermal Patch Sales YoY (2020-2031) & (K Units)
Figure 57. Asia-Pacific Absorbable Transdermal Patch Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Top 8 Manufacturers Absorbable Transdermal Patch Sales Revenue (US$ Million) in 2024
Figure 59. Asia-Pacific Absorbable Transdermal Patch Sales Volume (K Units) by Type (2020- 2031)
Figure 60. Asia-Pacific Absorbable Transdermal Patch Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 61. Asia-Pacific Absorbable Transdermal Patch Sales Volume (K Units) by Application (2020-2031)
Figure 62. Asia-Pacific Absorbable Transdermal Patch Sales Revenue (US$ Million) by Application (2020-2031)
Figure 63. Indonesia Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 64. Japan Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 65. South Korea Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 66. China Taiwan Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 67. India Absorbable Transdermal Patch Revenue (2020-2031) & (US$ Million)
Figure 68. Central and South America Absorbable Transdermal Patch Sales YoY (2020-2031) & (K Units)
Figure 69. Central and South America Absorbable Transdermal Patch Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Central and South America Top 5 Manufacturers Absorbable Transdermal Patch Sales Revenue (US$ Million) in 2024
Figure 71. Central and South America Absorbable Transdermal Patch Sales Volume (K Units) by Type (2021-2031)
Figure 72. Central and South America Absorbable Transdermal Patch Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Central and South America Absorbable Transdermal Patch Sales Volume (K Units) by Application (2020-2031)
Figure 74. Central and South America Absorbable Transdermal Patch Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. Brazil Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 76. Argentina Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 77. Middle East, and Africa Absorbable Transdermal Patch Sales YoY (2020-2031) & (K Units)
Figure 78. Middle East and Africa Absorbable Transdermal Patch Revenue YoY (2020-2031) & (US$ Million)
Figure 79. Middle East and Africa Top 5 Manufacturers Absorbable Transdermal Patch Sales Revenue (US$ Million) in 2024
Figure 80. Middle East and Africa Absorbable Transdermal Patch Sales Volume (K Units) by Type (2021-2031)
Figure 81. South America Absorbable Transdermal Patch Sales Revenue (US$ Million) by Type (2020-2031)
Figure 82. Middle East and Africa Absorbable Transdermal Patch Sales Volume (K Units) by Application (2020-2031)
Figure 83. Middle East and Africa Absorbable Transdermal Patch Sales Revenue (US$ Million) by Application (2020-2031)
Figure 84. GCC Countries Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 85. Turkey Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 86. Egypt Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 87. South Africa Absorbable Transdermal Patch Revenue (2020-2025) & (US$ Million)
Figure 88. Absorbable Transdermal Patch Industry Chain Mapping
Figure 89. Regional Absorbable Transdermal Patch Manufacturing Base Distribution (%)
Figure 90. Global Absorbable Transdermal Patch Production Market Share by Region (2020-2031)
Figure 91. Absorbable Transdermal Patch Production Process
Figure 92. Regional Absorbable Transdermal Patch Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
